Self-sampling for Non-participants in an Organised Cervical Cancer Screening Programme
- Conditions
- Cervical Cancer
- Interventions
- Behavioral: HPV self-sampling kit mailed directlyBehavioral: HPV self-sampling kit on demandBehavioral: Second reminder
- Registration Number
- NCT02680262
- Lead Sponsor
- University of Aarhus
- Brief Summary
The trial will evaluate the effect on participation in organised screening programme of a human papilloma virus (HPV) self-sampling kit directly mailed home or mailed on demand compared with the standard second reminder for regular screening.
- Detailed Description
The CHOice trial is a parallel randomised controlled, open label trial. Participants will be equally randomised into three arms: 1) Directly mailed a second reminder including a HPV self-sampling kit; 2) Mailed a second reminder offering a HPV self-sampling kit, to be ordered by e-mail, by text message, by phone, or by website; and 3) Mailed a second reminder for a conventional practitioner-collected sample (control group).
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 9327
- Women resident in the Central Denmark Region who have not participate in cervical cancer screening after an invitation and one reminder
- Women younger than 30 years are not included due to the lower specificity of HPV DNA tests in younger women
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Intervention group 1 HPV self-sampling kit mailed directly HPV self-sampling kit mailed directly Intervention group 2 HPV self-sampling kit on demand HPV self-sampling kit on demand Intervention group 3 Second reminder second reminder
- Primary Outcome Measures
Name Time Method Women who participate by returning a HPV self-sampling kit or having a practitioner-collected sample in the intervention groups compared to the proportion of women who have a practitioner-collected sample in the control group at 90 days after mail out. 90 days Primary outcome will be the proportion of women who participate by returning a HPV self-sampling kit or having a practitioner-collected sample in the intervention groups compared to the proportion of women who have a practitioner-collected sample in the control group at 90 days after mail out.
- Secondary Outcome Measures
Name Time Method Women with a positive HPV self-collected sample who attend follow-up testing at 30, 60 or 90 days after mail out. 30,60 or 90 days Secondary outcome will be the proportion of women with a positive HPV self-collected sample who attend follow-up testing at 30, 60 or 90 days after mail out of results
Trial Locations
- Locations (1)
Mette Tranberg Nielsen
🇩🇰Randers, Randers NØ, Denmark